First Time At Scientific Sessions – My Impressions
This was my first time at scientific sessions. As a stroke neurologist, it’s not one of the conferences on my calendar but I am happy I got to attend it this year. It’s heavily geared towards cardiology with some component of stroke and peripheral vascular disease. I got exposed to a lot of cutting edge cardiology research and met a lot of bright individuals with passion for cardiovascular disease.
My favorite session
I really enjoyed the opening session where AHA President & CEO talked about recent achievements by AHA and laid out future goals. Several awards were presented to researchers and clinicians. I have already written about the moving speech by Dr. Houser in the opening session in my previous blog.
Most interesting trial
PIONEER AF-PCI trial presented at the Scientific Session was the most interesting trial for me. I, as a stroke neurologist always worry about intracranial hemorrhage when the patient is on dual-antiplatelet agents and in addition, needs to be on anticoagulation. This trial tried to answer this question. It showed that the group on low dose rivaroxaban and DAPT had lower risk of clinically significant bleeding as compared to the group on DAPT and vitamin K antagonist. .
Favorite place to hang out at the conference
Technology hall was a great place to walk around and interact with different people. There were numerous exhibits from pharmaceutical companies, device manufacturers, publishing houses and others. In addition to that, the AHA simulation centers were also located there. These simulations were quite interactive and educational. The posters were also located in the technology hall which increased the traffic to the poster sessions.
Different experience at the sessions
I had a chance to attend one of the embargoed press briefings one day. This was a very different experience for me as I have not attended a press briefing before. The studies presented at the briefing were presented later that day at the main session and published in journals subsequently. Some press members were quite up to date on the studies that were being presented and asked very good questions which would have needed good background knowledge.
Overall, it was a good educational experience. I really liked meeting some of the other early career bloggers and AHA staff.
Mud Alvi is an Assistant Professor of Neurology at West Virginia University. His research interest includes Cerebral Small Vessel Disease and its association with Stroke and Dementia. He tweets @wvstrokedoc